Nitric oxide regulates actin reorganization through cGMP and Ca2+/calmodulin in RAW 264.7 cells  by Ke, XinChen et al.
Nitric oxide regulates actin reorganization through cGMP
and Ca2/calmodulin in RAW 264.7 cells
XinChen Ke, Masaharu Terashima, Yuko Nariai, Yukie Nakashima, Toumei Nabika,
Yoshinori Tanigawa *
Department of Biochemistry, Shimane Medical University, Izumo 693-8501, Japan
Received 23 November 2000; received in revised form 21 March 2001; accepted 26 March 2001
Abstract
Nitric oxide (NO) has been reported to be involved in the regulation of pseudopodia formation, phagocytosis and adhesion
in macrophages through the reorganization of actin. In the present study, we directly separated the globular (G) and
filamentous (F) actin from quiescent or NO-stimulated macrophage-like cell line RAW 264.7 cells in order to investigate the
dynamic redistribution of actin pools. We also focused on the regulatory mechanisms of actin assembly, induced by NO and
its possible subsequent signaling pathway. We showed that predominant G-actin coexisted with Triton X-100-insoluble
filamentous (TIF) and Triton X-100-soluble filamentous actin in resting RAW 264.7 cells. The exogenous NO produced by
( þ )-(E)-2-[(E)-hydroxyimino]-6-methoxy-4-methyl-5-nitro-3-hexenamide (NOR1), the endogenous NO induced by lipo-
polysaccharide (LPS) plus interferon-Q (IFNQ), and dibutyryl-cGMP increased the contents of TIF-actin in dose- and time-
dependent manners and altered its morphology. The increase in the TIF-actin contents induced by NOR1 or LPS plus IFNQ
was efficiently blocked by the radical scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide and the
soluble guanylate cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one or the arginine analogue NG-monomethyl-L-
arginine acetate, respectively. Preincubation with the calmodulin antagonist W-7 almost completely blocked the NO-induced
TIF-actin increase and morphological change. On the other hand, preincubation with C3 transferase, an inhibitor of Rho
protein, efficiently prevented the change in cell morphology, but had no effect on the TIF-actin increase. We postulate that
cGMP and subsequent Ca2/calmodulin may be key regulators of actin reorganization in NO-stimulated RAW 264.7
cells. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Macrophages are members of a host-wide cell sys-
tem that participates in the regulation of cell prolif-
eration, homeostasis, in£ammation, and defense
against both microbial and neoplastic diseases. Sev-
eral speci¢c functional processes of macrophages re-
quire rapid membrane morphologic modi¢cation.
For example, granular antigens are ¢rst bound and
phagocytized into macrophages through FcQR and
C3bR on the macrophage membrane surface and
degraded to small soluble molecules of polypeptides
inside the phagolysosome; then the molecules bind to
major histocompatibility complex II (MHC-II) on
the membrane surface and are transferred or pre-
sented to T cells by dendritic cells [1,2].
Actin is one of the most important constituents of
proteins found in all eukaryotes. It has a molecular
mass close to 43 000 Da due to the high degree of
conservation of amino acid sequence and number.
Besides muscle contraction, actin is involved in
many processes such as phagocytosis, secretion, cell
migration, and the maintenance of cell shape [3].
Structurally and functionally distinct polymers coex-
ist with actin monomers in cells [4]. The plasma
membrane of eukaryotic cells is supported by a net-
work of actin ¢laments. The actin cytoskeleton is
believed to provide both the protrusive and contrac-
tile forces required for cell motility, via a combina-
tion of actin polymerization, depolymerization, actin
¢lament cross-linking, and the interaction of actin-
binding proteins with actin ¢laments [5]. Because cell
movement is a dynamic process, actin at the leading
edge of the cell must be continuously depolymerizing
and recycling the actin subunits for further rounds of
polymerization. In this way, an individual actin mol-
ecule is constantly moving from and to di¡erent actin
pools that alter with the shift of dynamic level when
the milieu changes.
Nitric oxide (NO), a radical gas, has been estab-
lished as a di¡usible universal messenger mediating a
wide array of physiological and pathological activ-
ities in neural, vascular, and immune systems [6]. NO
exerts several protective functions: causing vasodila-
tion and thereby improving tissue perfusion, inhibit-
ing platelet aggregation and thus acting as an anti-
thrombotic agent [7], inhibiting leukocyte adhesion
to endothelial cells and recruitment of in£ammatory
cells [8,9], and inhibiting smooth muscle cell prolif-
eration and thereby preserving tissue and organ ar-
chitecture [10]. Besides mediating normal functions,
NO has been implicated in pathophysiologic states as
diverse as septic shock, stroke, and neurodegenera-
tive diseases [6,11,12]. NO synthesis is catalyzed by
the NO synthases (NOSs), and NOS isoforms are
classi¢ed into constitutive enzymes (eNOS and
nNOS) or an inducible enzyme (iNOS) that is typi-
cally induced in response to in£ammatory or proin-
£ammatory mediators [6,13]. Soluble guanylate cy-
clase (sGC) catalyzes the conversion of guanosine
5P-triphosphate (GTP) to cyclic guanosine 3P :5P-
monophosphate (cGMP), and the cyclase is accepted
to be a conclusive receptor for NO. The activation of
sGC and the subsequent accumulation of cGMP
transmit NO signals to the downstream elements of
the signaling cascade: cGMP-dependent protein ki-
nase, cGMP-gated cation channels, and cGMP-regu-
lated phosphodiesterase [14].
NO is known to be involved in dynamic morpho-
logical and mobility changes in several cells. For in-
stance, NO alters cell shape and motility in aortic
smooth muscle cells via protein tyrosine phosphatase
1B activation [10], or induces dose-dependent Ca2
transients and causes temporal morphological hyper-
polarization in human neutrophils [15]. NO and
cGMP regulate endothelial permeability and ¢lamen-
tous (F) actin distribution in hydrogen peroxide-
treated endothelial cells [16]. It has been reported
that NO may be involved in pseudopodia formation,
phagocytic activity, and adhesion in macrophages
through the modi¢cation of actin [17]. However,
the in£uence of NO on the actin pools and its down-
stream pathway remains obscure. Thus, we investi-
gated the distribution of actin pools by exogenous
and endogenous NO in murine macrophage cell
line RAW 264.7 cells. We also focused on the regu-
latory mechanisms of actin assembly induced by NO
and its possible signal pathway. In order to con¢rm
that alteration of actin contents is induced by NO, we
chose a NO donor, ( þ )-(E)-2-[(E)-hydroxyimino]-
6-methoxy-4-methyl-5-nitro-3-hexenamide (NOR1),
that automatically produces pure NO. We show
here that a predominant globular (G) actin pool co-
exists with two F-actin pools in resting RAW 264.7
cells. Exogenous and endogenous NO increased Tri-
ton X-100-insoluble actin contents and altered cell
BBAMCR 14749 21-5-01
X.-C. Ke et al. / Biochimica et Biophysica Acta 1539 (2001) 101^113102
morphology. Furthermore, we suggest that cGMP
and Ca2/calmodulin may be key regulators of NO-
induced actin reorganization in RAW 264.7 cells.
2. Materials and methods
2.1. Reagents
Mouse anti-actin monoclonal antibody was pur-
chased from Chemicon International, and anti-
mouse horseradish peroxidase (HRP)-conjugated
IgG was from Medical and Biological Laboratories.
NOR1, S-nitroso-N-acetyl-DL-penicillamine (SNAP),
2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-
1-oxyl 3-oxide (carboxy-PTIO), C3 ADP-ribo-
syltransferase, NG-monomethyl-L-arginine, acetate
(NGMMA) were from Wako Pure Chemical Indus-
tries (Japan). Dibutyrylguanosine 3P :5P-cyclic mono-
phosphate (DBcGMP) and calmodulin antagonist
W-7 were from Seikagaku (Japan). N4,2P-O-Dibutyr-
ylcytidine 3P :5P-cyclic monophosphate (DBcAMP)
and 1H-[1,2,4]oxadiazolo-[4,3-a]quinoxalin-1-one
(ODQ) were bought from Sigma. Lipopolysaccharide
(LPS) (Escherichia coli, 0127:B8 Westphal type)
was obtained from Difco Laboratories (Detroit,
MI, USA). Recombinant mouse interferon-Q (IFNQ)
was purchased from Genzyme (Cambridge, MA,
USA). N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)phallaci-
din (NBD-phallacidin) was from Molecular Probes
(USA).
2.2. Cell culture
The mouse macrophage-like cell line RAW 264.7
was obtained from the Riken Cell Bank (Japan) and
maintained in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 10% heat-inactivated
fetal bovine serum at 37‡C in a humidi¢ed atmos-
phere of 5% CO2 in air. The cells (1U106 cells/well)
were seeded into six-well cell culture dishes (Nunc).
Cellular viability during all experiments was deter-
mined by cell number and trypan blue dye exclusion
test (cell survival rate: 95%).
2.3. Preparation of the actin pools
Actin pools were separated using the method de-
scribed by Watts [4]. RAW 264.7 cells treated with or
without NOR1 were scraped o¡, washed twice with
PBS, and lysed for 15 min at room temperature in
0.5 ml lysis bu¡er containing 1% Triton X-100, 10
mM imidazole (pH 7.2), 40 mM KCl, 10 mM EGTA
and 0.2 mM PMSF. Triton X-100-insoluble ¢lamen-
tous actin (TIF-actin) was maintained in the precip-
itate after a 15 min centrifugation at 16 000Ug. The
supernatant was further separated by ultracentrifuga-
tion at 105 000Ug for 1 h. Triton X-100-soluble ¢l-
amentous actin (TSF-actin) was then located in the
precipitate, and G-actin was retained in the super-
natant. Each resultant F-actin preparation was re-
solved into 50 Wl of lysis bu¡er containing 2%
SDS. The protein concentration of samples was de-
termined by the method of Bradford using bovine
serum albumin as a standard [18].
2.4. Western blot analysis
Actin samples separated using 12.5% SDS-PAGE
were electrotransferred to nitrocellulose membranes.
The membranes were then incubated with 0.5% oval-
bumin in PBS containing 0.05% Tween 20 (PBS-T)
for 1 h, washed, and exposed to mouse anti-actin
monoclonal antibody for 1 h. After being washed
with PBS-T four times, the membranes were incu-
bated for 1 h with HRP-conjugated anti-mouse
IgG. Protein bands were visualized using an en-
hanced chemiluminescence (ECL) detection system
(Amersham Pharmacia Biotech.). Laser densitomet-
ric analysis was carried out using a LKB 2222-020
Ultroscan XL laser densitometer (Bromma, Sweden).
2.5. Determination of NO32 production and cGMP
accumulation in RAW 264.7 cells
RAW 264.7 cells were incubated with LPS (1.0 Wg/
ml) and IFNQ (100 U/ml) in the presence or absence
of 0.1^0.4 mM NGMMA for 18 h. Cell-free super-
natant was collected, and the nitrite concentration
was measured and used to provide indirect estimates
of NO production as described previously [19].
Brie£y, aliquots of the conditioned medium (100 Wl)
were incubated with 10 Wl of 0.005% 2,3-diamino-
naphthalene for 15 min at room temperature. The
reaction was terminated by adding 5 Wl of 2.8 M
NaOH. Each sample was diluted with distilled water
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to 4 ml, and the £uorescence intensity was measured
with excitation and emission settings of 365 nm and
450 nm, respectively, using a £uorescence spectro-
photometer (Hitachi 850 type).
cGMP accumulated in the NOR1-stimulated
RAW cells was measured using an enzyme immuno-
assay (EIA) kit (Amersham Pharmacia Biotech.)
under the manufacturer’s protocol. cGMP content
after treatment with DBcGMP or DBcAMP failed
to be determined accurately in this study, probably
because of their cross-reactivity to the antiserum of
the EIA system.
2.6. NBD-phallacidin staining and £ow cytometric
analysis
RAW 264.7 cells incubated with 0.5 mM NOR1
and/or 1 mM carboxy-PTIO or LPS (1.0 Wg/ml) plus
IFNQ (100 U/ml) were washed twice and suspended
in 0.9 ml of HBSS. The cells were ¢xed, permeabi-
lized, and stained by addition of 0.1 ml of 37% phos-
phate-bu¡ered formalin containing 3.3 WM NBD-
phallacidin and 200 Wg/ml lysophosphatidylcholine
for 10 min at 37‡C [20], then washed three times,
and resuspended in a bu¡er containing 140 mM
KCl, 1 mM MgCl2, 1 mM ATP, 10 mM glucose,
10 mM HEPES, 1 mM EGTA, and 0.2 mM CaCl2.
The cells were ¢ltered through a 50 Wm nylon mesh
¢lter to remove large aggregates. NBD-phallacidin-
stained cells (10 000 cells per sample) were analyzed
by £ow cytometry using FACStar (Becton Dickson
Immunocytometry Systems). The shift in the popu-
lation distribution of the £uorescence was taken as
an index of actin polymerization.
2.7. Confocal laser scanning microscopy (CLSM)
Cells seeded on micro slide glasses in six-well
plates (Nunc) treated with 0.5 mM NOR1, 1 mM
DBcGMP, or LPS (1.0 Wg/ml) plus IFNQ (100 U/
ml) were ¢xed, permeabilized, and stained by addi-
tion of 0.1 ml of 37% phosphate-bu¡ered formalin
containing 3.3 WM NBD-phallacidin and 200 Wg/ml
lysophosphatidylcholine for 20 min at 37‡C. The
slides were then taken out carefully, washed and
dried in the dark, and the stained cells were observed
by CLSM as described previously [21]. Photographs
were taken on Kodak Plus-X Pan 125 ¢lm.
2.8. Statistical analysis
Data are presented as the means þ S.E.M. for the
indicated number of independent experiments. Statis-
tical signi¢cance was evaluated by Student’s t-test
and P values of less than 0.05 were considered sig-
ni¢cant.
3. Results
3.1. Distribution of actin pools in resting RAW 264.7
cells
We determined the distribution of distinct actin
pools in resting RAW 264.7 cells in the ¢rst series
of experiments. Due to the di¡erent combinations
that exist, we separated F-actin into two types ac-
cording to the method of Watts [4]. One is TIF-actin,
the massive part of which participates in the consti-
tution of the cytoskeleton, and the other is TSF-ac-
tin, short cytoplasmic ¢laments capped with gelsolin.
The third actin pool is monomeric G-actin. To quan-
tify the proteins in the cell lysates, Western blot and
laser densitometric analysis were carried out. As
shown in Fig. 1, RAW 264.7 cells contain de¢ned
pools of actin. The total cellular actin contents of
cells is noted to be 866.1 þ 41.06 ng/106 cells. The
apportionment of actin was: TIF-actin, 164.5 þ 9.15
ng/106 cells; TSF-actin, 18.8 þ 8.14 ng/106 cells; and
G-actin, 682.8 þ 41.99 ng/106 cells (n = 4).
Fig. 1. Western blot analysis of actin pools in resting RAW
264.7 cells. Actin samples were prepared as described in Section
2, and then subjected to SDS-PAGE and ECL Western blot
analysis. Lanes: 1, sample bu¡er only; 2, TIF-actin; 3, G-actin;
4, TSF-actin.
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There is a predominant G-actin pool in the quies-
cent cells, giving potentiating formation of large
amounts of F-actin rapidly when the cells undergo
speci¢c situations. Liu and Sundqvist reported that
NO produced by hydrogen peroxide or phorbol myr-
istate acetate altered permeability and redistributed
F-actin, producing a rise in F-actin contents in bo-
vine aortic endothelial cells [16,22]. Thus, we inves-
tigated the e¡ect of NO on the F-actin contents in a
macrophage cell line.
3.2. E¡ect of NOR1 on the distribution of actin pools
in RAW 264.7 cells
We used NOR1 and SNAP as involuntary NO
donors to investigate the e¡ect of NO on the distri-
bution of each actin pool in RAW 264.7 cells. As
shown in Table 1, we measured the NO32 production
of NOR1 by the £uorescent method using 2,3-diami-
nonaphthalene and con¢rmed that NO32 production
correlated with the increasing concentrations of these
compounds in the culture medium as described else-
where [23,24].
When the RAW 264.7 cells were incubated with
0.5 mM NOR1 for 1, 2, and 4 h, the cellular actin
pools were evidently redistributed (Fig. 2A). TIF-ac-
tin increased signi¢cantly after 1 h of stimulation and
reached a maximum at 4 h. A similar dose-dependent
increase was also seen (Fig. 2B). On the contrary,
monomeric G-actin decreased with increasing TIF-
actin contents in both time- and dose-dependent
manners, although the change was not signi¢cant
(Fig. 2A,B). The increased percentage of TIF-actin
may come from the predominant G-actin pool,
whose population was su⁄cient to support the in-
crease of TIF-actin contents. In addition, we used
another pure NO donor, SNAP, a stable S-nitroso-
thiol [24]. After 2 h incubation, 0.5 mM SNAP in-
duced a signi¢cant increase of TIF-actin contents up
to 180.1 þ 5.774% (P6 0.008, compared with the val-
ue without SNAP).
Because the TSF-actin pool was tri£ing and re-
mained unchanged after NOR1 treatment (data not
shown), we will simply de¢ne TIF-actin contents as
the F-actin contents hereafter.
3.3. E¡ect of LPS plus IFNQ on the distribution of
actin pools
We considered whether the endogenously pro-
duced NO also regulates actin distribution, as was
seen in the case of the exogenous NO donor,
NOR1. To prove this, we treated the RAW cells
with LPS (1.0 Wg/ml) plus IFNQ (100 U/ml) in the
presence or absence of NGMMA, an iNOS inhibitor
[25], and measured the concentration of NO32 as an
estimate of the NO production and distribution of
actin pools in the cells. LPS plus IFNQ induced a
marked increase in the NO32 concentration in the
culture medium that was signi¢cantly inhibited by
NGMMA dose-dependently (Fig. 3A). As shown in
Fig. 3B, LPS and IFNQ induced a higher contents of
F-actin compared to that of the control. The increase
in F-actin contents was also signi¢cantly inhibited by
NGMMA dose-dependently, although no signi¢cant
change in the G-actin contents was observed (Fig.
3B). Thus, a positive correlation between NO con-
centrations and F-actin contents induced by LPS
Table 1
NO32 production, cGMP accumulation and change in the relative TIF-actin contents induced by NOR1, DBcGMP and DBcAMP
NO32 production (WM) cGMP (f mol/mg protein) relative TIF-actin (%)
Control 0.40 þ 0.020 185.00 þ 4.041 100
025 mM NOR1 111.25 þ 2.529* 367.67 þ 8.090* 147.67 þ 0.882*
0.5 mM NOR1 169.00 þ 3.719* 441.00 þ 18.193* 177.33 þ 5.044*
10 WM ODQ 0.40 þ 0.020 165.67 þ 8.686 90.67 þ 4.096
10 WM ODQ+0.5 mM NOR1 167.50 þ 3.227* 191.67 þ 11.780 104.33 þ 2.333
1.0 mM DBcGMP 0.40 þ 0.020 ^ 154.67 þ 2.906*
1.0 mM DBcAMP 0.40 þ 0.020 ^ 106.67 þ 5.840
The cells were treated with the indicated reagent for 2 h. The cell-free supernatant and cell lysate were subjected to determination of
the amounts of NO32 , the intracellular amounts of cGMP (n = 10) and relative TIF-actin contents (n = 3), respectively, as described in
Section 2. The data shown are means þ S.E.M. *P6 0.005, compared with control.
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plus IFNQ was clearly shown. These results con-
¢rmed that, whether induced exogenously or endoge-
nously, NO could mediate the redistribution of actin
pools.
3.4. Flow cytometry of the change in relative F-actin
contents
To assess how an NO-induced increase in F-actin
contents was expressed in RAW 264.7 cells, the cells
were treated with NOR1, LPS plus IFNQ, or NOR1
plus carboxy-PTIO, a NO scavenger [26]. Then the
cells were stained with NBD-phallacidin, which has
high a⁄nity to ¢lamentous but not to monomeric G-
actin, and the relative F-actin contents were analyzed
by £ow cytometry. As shown in Fig. 4, the cells
treated with both NOR1 and LPS plus IFNQ caused
a right shift of the cell population compared to that
of control (Fig. 4A: control, B: NOR1, and D: LPS
plus IFNQ). The right shift caused by NOR1 was
recovered by adding carboxy-PTIO (Fig. 4C). These
results indicated that NO derived from either an
exogenous donor or an endogenous source increased
the relative F-actin contents in the cells.
3.5. NO induces F-actin reorganization and
morphological modi¢cation
Because F-actin is an important component of the
cellular structure, to see whether the increasing F-
actin contents a¡ect the cell shape, the morphology
of the cells treated with NO was observed by CLSM.
Fig. 3. E¡ects of LPS plus IFNQ and NGMMA on nitrite
(NO32 ) production and relative actin contents in RAW 264.7
cells. Cells were incubated with LPS (1.0 Wg/ml) plus IFNQ (100
U/ml) in the presence or absence of NGMMA (0.1 mM, 0.2
mM, 0.4 mM) for 18 h. The NO32 secreted into the medium
(A) and relative actin contents of the cells (B) were determined
as described in Section 2. The data shown are the means
þ S.E.M. of three independent experiments. *P6 0.002,
**P6 0.008, compared with the value of LPS+IFNQ.
Fig. 2. E¡ect of NOR1 on relative actin contents in RAW
264.7 cells. The cells were incubated with 0.5 mM NOR1 for
the indicated time (A), or for 2 h with increasing concentrations
of NOR1 (B). Actin samples were isolated and subjected to
SDS-PAGE and ECL Western blot analysis as described in Sec-
tion 2. The developed ¢lms were analyzed by laser densitome-
try. The data shown are the means þ S.E.M. of four independ-
ent experiments. *P6 0.005, **P6 0.008, compared with the
value without NOR1.
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While resting cells exhibited regular round shapes
(Fig. 5A), NOR1-induced reorganization in actin dis-
tribution of the cells led to a striking di¡erence in cell
morphology. Many cells were polarized and had an
extended oval-shaped con¢guration (Fig. 5B). In ad-
dition to this morphological change, NOR1 induced
cell polarization indicating cell migration [27]. Typi-
cally, one sharp side of the cells displayed long actin-
rich pseudopodia, characteristic of the leading edge
of a motile cell, whereas the opposite edge was
rounded or displayed retraction ¢bers, typical of
the trailing edge of a motile cell. The e¡ect of
NOR1 was completely blocked by carboxy-PTIO:
the cells remained round and unpolarized, and no
pseudopodium was seen (Fig. 5C).
3.6. In£uence of DBcGMP and DBcAMP on F-actin
contents and morphologic change
The only conclusively proven target for NO is gua-
nylate cyclase, which catalyzes the conversion of
GTP to cGMP [14]. To test whether NOR1 in£uen-
ces the RAW cells through cGMP, the cells were
treated with DBcGMP. As shown in Fig. 6, the in-
crease in F-actin contents was seen in both dose-
(Fig. 6A) and time-dependent (Fig. 6B) ways, as
was shown in the NOR1 treatment (see Fig. 2). Nei-
ther 4 or 8 mM DBcGMP nor prolonged incubation
over 4 h changed the F-actin contents any further
(data not shown). The cells were clearly observed
polarizing, with long pseudopodia as leading edges
and with round retraction ¢bers as trailing edges
(Fig. 5D). These results showed that not only NO
but also cGMP contributed equally to the actin re-
organization.
Next, we tested the e¡ect of DBcAMP on the actin
distribution in RAW 264.7 cells. When the cells were
treated with 1 mM DBcAMP for 2 h, the relative F-
actin contents were slightly increased, though the ex-
tent of the increase was less than that of DBcGMP
(Table 1 and see also Fig. 6A). It has been noted that
cAMP may modulate the NO/cGMP pathway in vas-
cular smooth muscle cells, and that there is cross-talk
between the cAMP- and cGMP-mediated signal
transduction systems [28]. Thus, DBcAMP may
partly mimic the e¡ect of cGMP on the F-actin con-
tent, although the e¡ect was not signi¢cant in this
study.
Fig. 4. Flow cytometric pro¢les for the e¡ects of exogenous or
endogenous NO on the actin contents in RAW cells. Cells were
incubated with (A) medium alone, (B) 0.5 mM NOR1 for 2 h,
(C) 0.5 mM NOR1 and 1 mM PTIO for 2 h, and (D) 1.0 Wg/
ml LPS and 100 U/ml IFNQ for 18 h, and then treated with
NBD-phallacidin followed by £ow cytometric analysis as de-
scribed in Section 2. The data shown are representative of four
independent experiments.
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3.7. E¡ect of ODQ on cGMP accumulation and
increase in F-actin contents induced by NOR1
To con¢rm the NOR1-induced actin reorganiza-
tion could be mediated through cGMP, we measured
NOR1-induced cGMP production in the cells by
EIA, and further investigated the e¡ect of the soluble
guanylate cyclase inhibitor ODQ [29] on NOR1-in-
duced increase in F-actin contents. As shown in Ta-
ble 1, the accumulation of both NO32 and cGMP is
in proportion to the increasing concentration of
NOR1, suggesting that NOR1 apparently induced
cGMP production in RAW 264.7 cells. When 10
WM ODQ was added to the culture medium,
NOR1-induced cGMP accumulation was e¡ectively
blocked, and the NOR1-induced increase in F-actin
contents was signi¢cantly reduced. These results
clearly show that NOR1 and the subsequently pro-
duced cGMP are involved in the regulation of actin
reorganization.
3.8. In£uence of W-7 on F-actin contents and
morphological alteration induced by NOR1
It has been reported that NO donors such as
SNAP, NOR1 and sodium nitroprusside (SNP) can
increase the intracellular calcium concentration in
cultured nodes of ganglion neurons or single PU5-
Fig. 5. NOR1- and DBcGMP-induced actin reorganization in RAW 264.7 cells. Cells seeded on cover glasses were incubated for 2 h
with medium alone (A), 0.5 mM NOR1 (B), 0.5 mM NOR1 plus 1 mM PTIO (C) and 1 mM DBcGMP (D) as described in Section
2. Then the cells were permeabilized, ¢xed, stained and subjected to confocal laser scanning microscopy using a U10 eyepiece and a
U40/1.3 oil immersion objective.
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1.8 cells [30,31]. To investigate the signaling pathway
of the cytoskeletal and the morphologic modi¢cation
induced by NO in RAW cells, the cells were incu-
bated with the calmodulin antagonist W-7 for 1 h
before NOR1 was added. Fifty WM W-7 completely
blocked the NOR1-induced increase in F-actin con-
tents (Fig. 7A), and W-7 dose-dependently prevented
cell morphological change induced by NOR1 (Fig.
8C,D). Furthermore, W-7 inhibited the DBcGMP-
induced increase in F-actin contents (data not
shown), indicating that Ca2/calmodulin or calmod-
ulin-dependent kinase might locate in the down-
stream pathway of NO and cGMP. These results
indicate that NO, cGMP and Ca2/calmodulin may
be involved in the redistribution of actin.
3.9. E¡ect of Rho protein on F-actin contents and
morphological alteration induced by NOR1
To test whether Rho proteins are involved in the
increase in F-actin contents, the RAW cells were
preincubated for 16 h with 0.02 Wg/ml C3 transferase,
which ADP-ribosylates Rho protein and disrupts its
function, then NOR1 was added and incubated for a
further 2 h. C3 had no e¡ect on the increase in the
Fig. 7. E¡ects of the calmodulin inhibitor W-7 and C3 ADP-ri-
bosyltransferase on F-actin contents in RAW cells treated with
NOR1. Cells were preincubated with 50 WM W-7 for 1 h or
0.02 Wg/ml C3 for 16 h, then 0.5 mM NOR1 was added for an-
other 2 h. The e¡ects of W-7 (A) and C3 (B) on relative F-ac-
tin contents are shown. The data shown are the means þ S.E.M.
of three independent experiments. *P6 0.005, compared with
control value; **P6 0.005, compared with the value of NOR1.
Fig. 6. E¡ect of DBcGMP on actin contents in RAW 264.7
cells. The cells were treated with various concentrations of
DBcGMP for 2 h (A) or with 1.0 mM DBcGMP for the indi-
cated time (B). Actin samples were then isolated and submitted
to SDS-PAGE and ECL Western blot analysis as described in
Section 2. The developed ¢lms were analyzed by laser densitom-
etry. The data shown are the means þ S.E.M. of three independ-
ent experiments. (A) *P6 0.05, **P6 0.005, compared with the
basal value. (B) *P6 0.05, **P6 0.005, compared with the val-
ue without DBcGMP.
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F-actin contents induced by NOR1 (Fig. 7B). On the
other hand, 0.02 Wg/ml C3 completely prevented
NOR1-induced morphologic change: the cells re-
mained round like the control (Fig. 8E). Rho protein
is recognized as a key regulator of the actin cytoskel-
eton [32,33], although these results indicate that Rho
protein may not be involved in NO-induced actin
reorganization.
Fig. 8. E¡ects of the calmodulin inhibitor W-7 and C3 ADP-ribosyltransferase on morphology in RAW cells treated with NOR1.
Cells seeded on cover glasses were preincubated with 25 or 50 WM W-7 for 1 h or 0.02 Wg/ml C3 for 16 h, then 0.5 mM NOR1 was
added for another 2 h. The cells were permeabilized, ¢xed, stained and subjected to CLSM as described in Section 2. (A) Control;
(B) NOR1; (C) 25 WM W-7; (D) 50 WM W-7; (E) C3.
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4. Discussion
Actin has long received attention as an important
component of the cytoskeleton because of its dynam-
ic involvement in cell mobility and functions in eu-
karyotes. In the present study, we quanti¢ed the G-
and F-actin contents from NO-stimulated macro-
phage-like cell line RAW 264.7 cells in order to in-
vestigate the dynamic redistribution of actin contents
in addition to the £uorescent microscopic analysis.
We demonstrated that the predominant G-actin co-
existed with TIF- and TSF-actin in quiescent RAW
264.7 cells. Both NOR1 and LPS plus IFNQ, or
DBcGMP increased the contents of TIF-actin in
dose- and time-dependent manners, and the cells be-
came oval, polarized and extended long actin-rich
pseudopodia. We con¢rmed that exogenous or en-
dogenous NO and subsequent cGMP production
could be involved in the regulation of actin reorgan-
ization by using carboxy-PTIO, NGMMA and ODQ,
respectively. Carboxy-PTIO, a scavenger of free rad-
ical NO [26], blocked NOR1-induced actin reorgan-
ization analyzed by FACS and CLSM (Fig. 3B,C;
Fig. 4B,C). NGMMA, a useful NOS inhibitor be-
cause of its chemical stability, low toxicity and ap-
parent speci¢city for NOS [25], simultaneously inhib-
ited NO32 production and actin reorganization
induced by LPS plus IFNQ (Fig. 3). Furthermore,
ODQ, a speci¢c inhibitor of NO-dependent soluble
guanylate cyclase [29], blocked the NOR1-induced
increase in both cGMP concentration and the change
in F-actin contents (Table 1). These results clearly
show that NO and cGMP are the key regulators of
actin reorganization. Preincubation with the calmod-
ulin antagonist W-7 almost completely blocked the
NO-induced TIF-actin increase and morphological
change. On the other hand, preincubation with C3
transferase, an inhibitor of Rho protein, e⁄ciently
prevented morphological change in the cells, but
had no e¡ect on the increase in TIF-actin contents.
Thus, Ca2/calmodulin may follow the NO-cGMP
pathway in RAW 264.7 cells.
NO and its second messenger cGMP transmit sig-
nals to downstream elements such as cGMP-depen-
dent protein kinases, cGMP-gated cation channels,
and cGMP-regulated phosphodiesterase [14]. It has
been reported that NO donors such as SNAP,
NOR1, and SNP increased the intracellular calcium
concentration in cultured nodose ganglion neuron or
single PU5-1.8 cells, a murine macrophage cell line
[30,31]. Clementi reported that almost all regulatory
mechanisms involved in the control of Ca2 homeo-
stasis seem to be modulated by NO, although the
interaction of NO with Ca2 homeostasis may be
cell-speci¢c in many cases [34]. In the present study,
W-7 completely blocked the NO- and DBcGMP-in-
duced increase in F-actin contents and morphologi-
cal change, indicating that Ca2/calmodulin may also
be involved in the NO- and cGMP-induced signaling
pathway in RAW 264.7 cells. In fact, Wang et al.
reported that NO signaling mediates stimulation of
Ca2 current elicited by the withdrawal of acetylcho-
line in cat atrial myocytes [35]. Furthermore, in hu-
man neutrophils, W-7 had dual e¡ects on fMLP-in-
duced actin polymerization [36]. Taken together with
the above results and our data, we suggest that NO
and subsequent cGMP may act through Ca2/cal-
modulin to increase the F-actin contents, thus result-
ing in actin reorganization and morphological alter-
ation.
The small GTP-binding proteins of the Rho family
have a close relationship with the rearrangement of
the actin network. Several studies indicate the partic-
ipation of Rho GTPases in the regulation of cell
shape and motility [32,33]. In the present study, a
Rho inhibitor, C3 exoenzyme, e⁄ciently prevented
the NOR1-induced shape change of the cells, but
had no e¡ect on the increase in F-actin contents.
These results suggest that Rho protein might func-
tion in the submembranous portion to coordinate the
actin network, but it does not take part in NO-in-
duced actin reorganization in RAW 264.7 cells.
It has been reported that NO produced by phorbol
myristate acetate or hydrogen peroxide reduces the
endothelial permeability and increases the dense pe-
ripheral bands of actins or alternatively increases the
F-actin contents in endothelial cells [16,22]. These
e¡ects indicated that NO and cGMP may have a
role in regulating F-actin distribution in the endothe-
lial cells. On the contrary, NO induced by SNP de-
creased pseudopodia formation estimated by rhod-
amine-phalloidine staining, probably via ADP-
ribosylation of actin in murine macrophages [17]. It
has been noted that SNP may possess some as yet
unknown action other than NO production, unlike
the pure production of NO by NOR1 or SNAP,
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because the nitroprusside anion is a coordinate com-
plex of a ferrous ion with ¢ve cyanide anions and a
nitrosonium ion [37,38]. Moreover, in the present
study, we detected no ADP-ribosylation of actin in-
duced by NO (X.-C. Ke and M. Terashima, unpub-
lished observation) in addition to the reports of NO-
independent ADP-ribosylation of actin [39^41].
Thus, the unknown action by SNP other than NO
production might cause the di¡erent results.
Actin polymerization has accounted for the in-
volvement of many actin-binding proteins [3,5], indi-
cating that the NO- or subsequently produced
cGMP- or Ca2/calmodulin-induced alteration in
the function of the actin-binding proteins may have
a rational role in actin polymerization. We are now
investigating the precise mechanism of NO-induced
increase in F-actin contents.
In summary, we demonstrated that predominant
G-actin coexists with two F-actin pools in macro-
phage-like cell line RAW 264.7 cells. NO and
DBcGMP increased TIF-actin contents and altered
the cell morphology, and W-7 completely blocked
the NO-induced changes. We postulate that cGMP
and subsequent Ca2/calmodulin may be key regula-
tors of NO-induced actin reorganization in RAW
264.7 cells.
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